Jakavi 5 mg – 56 Tablets

Jakavi is a medication used to treat certain bone marrow disorders, including splenomegaly due to myelofibrosis and polycythemia vera, and may also be prescribed for other conditions as determined by a physician. It works by inhibiting JAK1 and JAK2 enzymes, which play a role in cell growth and blood production, helping to reduce symptoms and improve quality of life.

Indications:

• Treatment of intermediate or high-risk myelofibrosis (Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis)

• Treatment of polycythemia vera patients who are resistant to or intolerant of hydroxyurea

How to Use:

• Taken orally with or without food

• Follow the dosage prescribed by your doctor based on your condition and kidney/liver function

• Swallow tablets whole; do not crush or chew

Warnings & Precautions:

• May lower blood cell counts (red cells, white cells, platelets); regular blood monitoring is required

• Use with caution in patients with infections or liver/kidney problems

• Not recommended during pregnancy or breastfeeding unless prescribed by a doctor

• May increase the risk of infections or skin cancers

Possible Side Effects:

• Anemia

• Thrombocytopenia

• Dizziness or headache

• Bruising or bleeding

• Increased risk of infections

Storage:

• Store at room temperature (15–30°C)

• Keep away from moisture, light, and out of reach of children